MXPA05010629A - Vehiculo enmascarador del sabor para particulas de oxazolidinona recubiertas. - Google Patents
Vehiculo enmascarador del sabor para particulas de oxazolidinona recubiertas.Info
- Publication number
- MXPA05010629A MXPA05010629A MXPA05010629A MXPA05010629A MXPA05010629A MX PA05010629 A MXPA05010629 A MX PA05010629A MX PA05010629 A MXPA05010629 A MX PA05010629A MX PA05010629 A MXPA05010629 A MX PA05010629A MX PA05010629 A MXPA05010629 A MX PA05010629A
- Authority
- MX
- Mexico
- Prior art keywords
- particles
- oxazolidinone
- coated
- taste
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Abstract
La presente invencion esta dirigida a formulaciones secas de particulas de oxazolidinona recubiertas, tales como particulas de linezolid recubiertas, que, cuando estan suspendidas en una solucion acuosa, enmascaran el sabor de la oxazolidinona en el vehiculo de suspension resultante; especificamente, una mezcla de azucares en la formulacion, que comprende sorbitol y sacarosa, inhibe el transporte de masas de la oxazolidinona desde las particulas al vehiculo de suspension; se describen formulaciones secas de las particulas de oxazolidinona recubiertas, suspensiones de las mismas, y procedimientos de uso de las mismas para tratar o prevenir infecciones a partir de bacterias gram positivas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45938203P | 2003-03-31 | 2003-03-31 | |
PCT/IB2004/000921 WO2004087108A1 (en) | 2003-03-31 | 2004-03-19 | Taste-masking vehicle for coated oxazolidinone particles |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05010629A true MXPA05010629A (es) | 2005-12-12 |
Family
ID=33131883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05010629A MXPA05010629A (es) | 2003-03-31 | 2004-03-19 | Vehiculo enmascarador del sabor para particulas de oxazolidinona recubiertas. |
Country Status (7)
Country | Link |
---|---|
US (1) | US20040191326A1 (es) |
EP (1) | EP1610764A1 (es) |
JP (1) | JP2006522089A (es) |
BR (1) | BRPI0408854A (es) |
CA (1) | CA2519869A1 (es) |
MX (1) | MXPA05010629A (es) |
WO (1) | WO2004087108A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040170686A1 (en) * | 2003-01-31 | 2004-09-02 | Fredrickson Jennifer K. | Suspension vehicle for coated drug particles |
WO2010046933A2 (en) | 2008-10-22 | 2010-04-29 | Rubicon Research Private Limited | Pharmaceutical compositions of taste-masked linezolid |
AU2014235854B2 (en) | 2013-03-21 | 2019-04-11 | Eupraxia Pharmaceuticals USA LLC | Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith |
EP3193847A4 (en) * | 2014-09-19 | 2018-06-06 | Eupraxia Pharmaceuticals Inc. | Injectable microparticles for hyper-localized release of therapeutic agents |
PL3206672T3 (pl) | 2015-10-27 | 2018-09-28 | Eupraxia Pharmaceuticals Inc. | Preparaty o przedłużonym uwalnianiu środków znieczulających miejscowo |
CN105853351B (zh) * | 2016-03-31 | 2019-02-22 | 重庆华邦制药有限公司 | 利奈唑胺口服混悬液及其制备方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8103843L (sv) * | 1981-06-18 | 1982-12-19 | Astra Laekemedel Ab | Farmaceutisk mixtur |
US4994260A (en) * | 1982-05-28 | 1991-02-19 | Astra Lakemedel Aktiebolag | Pharmaceutical mixture |
IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
IT1183574B (it) * | 1985-05-08 | 1987-10-22 | Eurand Spa | Metodo per ottenere una sospensione estemporanea omogenea di microcapsule |
SE8605515D0 (sv) * | 1986-12-22 | 1986-12-22 | Astra Laekemedel Ab | A liquid dosage form for oral administration of a pharmaceutically active substance |
US4788220A (en) * | 1987-07-08 | 1988-11-29 | American Home Products Corporation (Del.) | Pediatric ibuprofen compositions |
US5164510A (en) * | 1988-09-15 | 1992-11-17 | The Upjohn Company | 5'Indolinyl-5β-amidomethyloxazolidin-2-ones |
US5082669A (en) * | 1989-07-20 | 1992-01-21 | Dainippon Pharmaceutical Co., Ltd. | Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked |
US5231188A (en) * | 1989-11-17 | 1993-07-27 | The Upjohn Company | Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents |
IT1246350B (it) * | 1990-07-11 | 1994-11-17 | Eurand Int | Metodo per ottenere una rapida sospensione in acqua di farmaci insolubili |
EP0610265B1 (en) * | 1991-11-01 | 1996-12-27 | PHARMACIA & UPJOHN COMPANY | Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents |
US5272137A (en) * | 1992-02-14 | 1993-12-21 | Mcneil-Pfc, Inc. | Aqueous pharmaceutical suspension for pharmaceutical actives |
TW271400B (es) * | 1992-07-30 | 1996-03-01 | Pfizer | |
EP0620001A1 (en) * | 1993-04-16 | 1994-10-19 | McNEIL-PPC, INC. | Aqueous pharmaceutical suspension and process for preparation thereof |
US5688792A (en) * | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
JP3698724B2 (ja) * | 1993-11-22 | 2005-09-21 | ファルマシア・アンド・アップジョン・カンパニー | 置換−ヒドロキシアセチルピペラジンフェニルオキサゾリジノンのエステル |
DE4425612A1 (de) * | 1994-07-20 | 1996-04-04 | Bayer Ag | 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone |
DE4425613A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
WO1996003976A1 (en) * | 1994-08-01 | 1996-02-15 | Kv Pharmaceutical Corporation | Tastemasked liquid pharmaceutical delivery system |
GB9601666D0 (en) * | 1996-01-27 | 1996-03-27 | Zeneca Ltd | Chemical compounds |
AUPN969796A0 (en) * | 1996-05-07 | 1996-05-30 | F.H. Faulding & Co. Limited | Taste masked liquid suspensions |
GB2318511A (en) * | 1996-10-23 | 1998-04-29 | Eurand Int | Process for the preparation of a pharmaceutical composition for rapid suspension in water |
AU764184B2 (en) * | 1998-01-23 | 2003-08-14 | Pharmacia & Upjohn Company | Oxazolidinone combinatorial libraries, compositions and methods of preparation |
FR2795962B1 (fr) * | 1999-07-08 | 2003-05-09 | Prographarm Laboratoires | Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif |
US6451345B1 (en) * | 2000-01-20 | 2002-09-17 | Eurand Pharmaceuticals Ltd. | Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration |
US6495154B1 (en) * | 2000-11-21 | 2002-12-17 | Vivus Inc. | On demand administration of clomipramine and salts thereof to treat premature ejaculation |
-
2004
- 2004-03-01 US US10/790,312 patent/US20040191326A1/en not_active Abandoned
- 2004-03-19 JP JP2006506396A patent/JP2006522089A/ja not_active Withdrawn
- 2004-03-19 CA CA002519869A patent/CA2519869A1/en not_active Abandoned
- 2004-03-19 MX MXPA05010629A patent/MXPA05010629A/es unknown
- 2004-03-19 EP EP04721966A patent/EP1610764A1/en not_active Withdrawn
- 2004-03-19 WO PCT/IB2004/000921 patent/WO2004087108A1/en active Application Filing
- 2004-03-19 BR BRPI0408854-9A patent/BRPI0408854A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2004087108A1 (en) | 2004-10-14 |
EP1610764A1 (en) | 2006-01-04 |
JP2006522089A (ja) | 2006-09-28 |
CA2519869A1 (en) | 2004-10-14 |
BRPI0408854A (pt) | 2006-04-04 |
US20040191326A1 (en) | 2004-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY145410A (en) | Method for preventing or treating respiratory infections and acute otitis media in infants | |
WO2008061243A3 (en) | Respiratory syncytial virus-virus like particle (vlps) | |
WO2007041156A3 (en) | Antibiotic formulations, unit doses, kits, and methods | |
CY1112004T1 (el) | Αερολυματοποιημενος συνδυασμος φωσφομυκινης/αμινογλυκοζιτη για την αγωγη των βακτηριδιακων αναπνευστικων λοιμωξεων | |
DE60327438D1 (de) | Amino-substituierte cyclohexan derivate zur behandlung bakterieller infektionen | |
HK1207828A1 (en) | Cell-derived viral vaccines with low levels of residual cell dna dna | |
WO2007117303A3 (en) | Combination vaccine comprising an attenuated bovine viral diarrhea virus | |
HUP0203056A1 (hu) | Vakcinakészítmény | |
WO2005023227A3 (en) | Nicotine formulations and use thereof | |
WO2006050489A3 (en) | Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions | |
WO2009154304A3 (en) | A pharmaceutical composition comprising rebamipide | |
WO2005074990A3 (en) | Methods of preventing and treating sars using low ph respiratory tract compositions | |
MY125356A (en) | Moxifloxacin/sodium chloride formulation | |
WO2006100081A3 (de) | Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung | |
WO2004094386A8 (en) | Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b) | |
WO2006074303A3 (en) | Delivery vehicles, bioactive substances and viral vaccines | |
WO2003026567A3 (en) | Use of neuraminidase inhibitors to prevent flu associated bacterial infections | |
HK1086487A1 (en) | Alpha-aminoamide derivatives useful as antimigraine agents | |
PT1057828E (pt) | Suspensoes de trovafloxacina para administracao oral | |
MXPA05010629A (es) | Vehiculo enmascarador del sabor para particulas de oxazolidinona recubiertas. | |
AUPQ761200A0 (en) | Compositions and methods for treatment of mucosal infections | |
HK1048064A1 (en) | Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses | |
NZ505894A (en) | Methylenebisbenzaldehyde derivatives, methylidynetrisphenol derivative and pharmaceuticals thereof; useful for treating or preventing pneumovirus infection and associated diseases | |
EP1114826A3 (en) | Novel antibacterial and prokinetic macrolides | |
WO2002072581A3 (en) | Pyrazolopyriadine derivatives |